Pathway Diagnostics has released the SensiTrop II assay, a new version of its SensiTrop assay that combines molecular heteroduplex tracking assay technology with molecular sequencing to determine the co-receptor tropism status of HIV-infected patients.
The company performs the assay in its CLIA-certified laboratory on samples received from national reference laboratories in the US and from Delphic Diagnostics in Europe.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.